Chapter 20 Cholinergic Drugs Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Chapter 48 Immunosuppressant Drugs Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
-
Upload
paul-carson -
Category
Documents
-
view
227 -
download
1
Transcript of Chapter 48 Immunosuppressant Drugs Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Chapter 48
Immunosuppressant Drugs
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
The purpose of the immune system is to distinguish self from nonself and to protect the body from foreign material (antigens), including cancer
Two types of immunity: humoral immunity, which is mediated by B lymphocytes, and cellular immunity, which is mediated by T lymphocytes
Immune System
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 2
Participates in anaphylactic reactions Responsible for rejection of kidney, liver, and
heart transplants Can also sometimes attack itself, causing
“autoimmune diseases” or immune-mediated diseases
Immune System (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 3
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 4
Drugs that decrease or prevent an immune response, thus suppressing the immune system
Used to prevent or treat rejection of transplanted organs
Immunosuppressants
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 5
All suppress certain T-lymphocyte cell lines, thus preventing their involvement in the immune response
Results in a pharmacologically immunocompromised state
Mechanisms of action vary according to drug
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 6
Major classes used to prevent organ rejection Glucocorticoids Calcineurin inhibitors Antimetabolites
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 7
cyclosporine (Sandimmune) azathioprine (Imuran) muromonab-CD3 (Orthoclone) daclizumab (Zenapax) sirolimus (Rapamune) basiliximab (Simulect) glatiramer acetate (Copaxone) tacrolimus (Prograf) mycophenolate mofetil (CellCept)
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 8
Indications vary from drug to drug Primarily indicated for the prevention of organ
rejection Muromonab-CD3, mycophenolate, and
tacrolimus are indicated for both prevention of rejection and treatment of organ rejection
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 9
Classroom Response Question
The nurse should question the prescriber regarding use of cyclosporine for the treatment of which disease?
A.Arthritis
B.Psoriasis
C.Irritable bowel disease
D.Multiple sclerosis
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 10
azathioprine (Imuran) Prophylaxis of organ rejection concurrently with other
immunosuppressant drugs, such as cyclosporine and corticosteroids
Also used in the treatment of rheumatoid arthritis
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 11
basiliximab (Simulect) and daclizumab (Zenapax) Monoclonal antibodies Used to prevent rejection of transplanted kidneys Generally used as part of a multidrug
immunosuppressive regimen that includes cyclosporine and corticosteroids
Have a tendency to cause the allergy-like reaction known as cytokine release syndrome
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 12
cyclosporine (Sandimmune) Prevention of organ rejection May be used for other autoimmune disorders
tacrolimus (Prograf) Used for the prevention of liver transplant rejection Others uses are unlabeled uses
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 13
Classroom Response Question
A patient who had a kidney transplant is receiving cyclosporine PO in maintenance doses. What action would decrease the potency of this drug?
A. Taking it with orange juice
B. Taking it with milk
C. Using a Styrofoam container to administer the drug
D. Mixing it with chocolate milk
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 14
glatiramer acetate (Copaxone) Works by blocking T-cell autoimmune activity against
myelin protein, which reduces the frequency of the neuromuscular exacerbations associated with multiple sclerosis
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 15
fingolimod (Gilenya) Failed as an antirejection drug Approved in 2010 for multiple sclerosis Only oral drug for relapsing forms of multiple sclerosis Significant adverse effects, including headache,
hepatotoxicity, flulike symptoms, back pain, AV block, bradycardia, hypertension, and macular edema, may occur
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 16
muromonab-CD3 (Orthoclone OKT3) Reversal and prevention of graft rejection Monoclonal antibody
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 17
mycophenolate (CellCept) Indicated for the prevention of organ rejection as well
as the treatment of organ rejection FDA black box warning for increased risk of
congenital malformations and spontaneous abortions when used during pregnancy
Common side effects include hypertension, hypotension, peripheral edema, tachycardia, pain, headache, hyperglycemia, hyperlipidemia, electrolyte disturbances, and others
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 18
Adverse effects vary according to drugs and may be devastating
All immunosuppressed patients have a heightened susceptibility to opportunistic infections
Immunosuppressants (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 19
Perform a thorough assessment before administering these drugs Renal, liver, and cardiovascular function studies CNS baseline function Respiratory assessment Baseline vital signs Baseline laboratory studies, including hemoglobin,
hematocrit, WBC, and platelet counts
Nursing Implications
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 20
Assess for contraindications, drug allergies, and drug interactions
Monitor WBC counts throughout therapy; if the count drops below normal range, contact the prescriber
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 21
Classroom Response Question
Which potential problem is of most concern for the patient receiving immunosuppressant drugs?
A. Orthostatic hypotension
B. Increased susceptibility to infections
C. Neurotoxicity
D. Peripheral edema
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 22
Oral immunosuppressants should be taken with food to minimize GI upset
Oral forms are used when possible to decrease the risk of infection that may occur with parenteral injections
Note that there are several possible drug interactions
Grapefruit juice also interacts with some of these drugs
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 23
Oral antifungal drugs are usually given with these drugs to treat oral candidiasis that may occur
Assess the oral cavity often for white patches on the tongue, mucous membranes, and oral pharynx
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 24
Mix oral cyclosporine solution in a glass container
Do not use Styrofoam containers because the drug adheres to the inside wall of the container
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 25
Follow guidelines for parenteral administration carefully
Inform patients that lifelong therapy with immunosuppressants is indicated with organ transplantation
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 26
Patients taking immunosuppressants should be encouraged to take measures to reduce the risk of infection Avoiding crowds Avoiding people with colds or other infections
Inform patients to immediately report fever, sore throat, chills, joint pain, fatigue, or other signs of a severe infection
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 27
Monitor for therapeutic responses Monitor for adverse effects and signs of drug
toxicity
Nursing Implications (cont’d)
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 28
Classroom Response Question
A male patient who received a kidney transplant 6 months ago is taking cyclosporine. The patient tells the nurse that he has started to take several herbal preparations. Which does not pose a possible problem for the patient?
A.St. John’s wort
B.Ginkgo
C.Cat’s claw
D.Echinacea
Copyright © 2014 by Mosby, an imprint of Elsevier Inc. 29